α-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro

被引:168
作者
Turnbull, S
Tabner, BJ
El-Agnaf, OMA
Moore, S
Davies, Y
Allsop, D [1 ]
机构
[1] Univ Lancaster, Dept Biol Sci, Lancaster LA1 4YQ, England
[2] Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England
关键词
Parkinson's disease; neurodegeneration; alpha-synuclein; hydrogen peroxide; hydroxyl radicals; electron spin resonance spectroscopy; free radicals;
D O I
10.1016/S0891-5849(01)00513-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some rare inherited forms of Parkinson's disease (PD) are due to mutations in the gene encoding a 140-amino acid presynaptic protein called alpha -synuclein. In PD, and some other related disorders such as dementia with Lewy bodies, alpha -synuclein accumulates in the brain in the form of fibrillar aggregates, which are found inside the neuronal cytoplasmic inclusions known as Lewy bodies. By means of an electron spin resonance (ESR) spin trapping method, we show here that solutions of full-length alpha -synuclein, and a synthetic peptide fragment of alpha -synuclein corresponding to residues 61-95 (the so-called non-A beta component or NAC), both liberate hydroxyl radicals upon incubation in vitro followed by the addition of Fe(II). We did not observe this property for the related beta- and gamma -synucleins, which are not found in Lewy bodies, and are not linked genetically to any neurodegenerative disorder. There is abundant evidence for the involvement of free radicals and oxidative stress in the pathogenesis of nigral damage in PD. Our new data suggest that the fundamental molecular mechanism underlying this pathological process could be the production of hydrogen peroxide by alpha -synuclein. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:1163 / 1170
页数:8
相关论文
共 37 条
[21]   Understanding cell death in Parkinson's disease [J].
Jenner, P ;
Olanow, CW .
ANNALS OF NEUROLOGY, 1998, 44 (03) :S72-S84
[22]  
Jenner P, 1998, MOVEMENT DISORD, V13, P24
[23]   Protein precipitation: a common etiology in neurodegenerative disorders? [J].
Kakizuka, A .
TRENDS IN GENETICS, 1998, 14 (10) :396-402
[24]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108
[25]   Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders [J].
Masliah, E ;
Rockenstein, E ;
Veinbergs, I ;
Mallory, M ;
Hashimoto, M ;
Takeda, A ;
Sagara, Y ;
Sisk, A ;
Mucke, L .
SCIENCE, 2000, 287 (5456) :1265-1269
[26]   The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease [J].
Miranda, S ;
Opazo, C ;
Larrondo, LF ;
Muñoz, FJ ;
Ruiz, F ;
Leighton, F ;
Inestrosa, NC .
PROGRESS IN NEUROBIOLOGY, 2000, 62 (06) :633-648
[27]   Copper(II)-induced self-oligomerization of α-synuclein [J].
Paik, SR ;
Shin, HJ ;
Lee, JH ;
Chang, CS ;
Kim, J .
BIOCHEMICAL JOURNAL, 1999, 340 :821-828
[28]   Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [J].
Polymeropoulos, MH ;
Lavedan, C ;
Leroy, E ;
Ide, SE ;
Dehejia, A ;
Dutra, A ;
Pike, B ;
Root, H ;
Rubenstein, J ;
Boyer, R ;
Stenroos, ES ;
Chandrasekharappa, S ;
Athanassiadou, A ;
Papapetropoulos, T ;
Johnson, WG ;
Lazzarini, AM ;
Duvoisin, RC ;
DiIorio, G ;
Golbe, LI ;
Nussbaum, RL .
SCIENCE, 1997, 276 (5321) :2045-2047
[29]   Morphology and toxicity of A beta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease [J].
Roher, AE ;
Chaney, MO ;
Kuo, YM ;
Webster, SD ;
Stine, WB ;
Haverkamp, LJ ;
Woods, AS ;
Cotter, RJ ;
Tuohy, JM ;
Krafft, GA ;
Bonnell, BS ;
Emmerling, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20631-20635
[30]   Induction of neuronal death by α-synuclein [J].
Saha, AR ;
Ninkina, NN ;
Hanger, DP ;
Anderton, BH ;
Davies, AM ;
Buchman, VL .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (08) :3073-3077